Two-component spike nanoparticle vaccine protects macaques from SARS-CoV-2 infection.


Journal

Cell
ISSN: 1097-4172
Titre abrégé: Cell
Pays: United States
ID NLM: 0413066

Informations de publication

Date de publication:
04 03 2021
Historique:
received: 03 11 2020
revised: 23 12 2020
accepted: 21 01 2021
pubmed: 13 2 2021
medline: 12 3 2021
entrez: 12 2 2021
Statut: ppublish

Résumé

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic is continuing to disrupt personal lives, global healthcare systems, and economies. Hence, there is an urgent need for a vaccine that prevents viral infection, transmission, and disease. Here, we present a two-component protein-based nanoparticle vaccine that displays multiple copies of the SARS-CoV-2 spike protein. Immunization studies show that this vaccine induces potent neutralizing antibody responses in mice, rabbits, and cynomolgus macaques. The vaccine-induced immunity protects macaques against a high-dose challenge, resulting in strongly reduced viral infection and replication in the upper and lower airways. These nanoparticles are a promising vaccine candidate to curtail the SARS-CoV-2 pandemic.

Identifiants

pubmed: 33577765
pii: S0092-8674(21)00078-7
doi: 10.1016/j.cell.2021.01.035
pmc: PMC7834972
pii:
doi:

Substances chimiques

Antibodies, Neutralizing 0
COVID-19 Vaccines 0
Spike Glycoprotein, Coronavirus 0
spike protein, SARS-CoV-2 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1188-1200.e19

Informations de copyright

Copyright © 2021 The Authors. Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of interests N.P.K. is a co-founder, shareholder, and chair of the scientific advisory board of Icosavax. The remaining authors declare no competing interests. Amsterdam UMC has filed a patent application concerning the SARS-CoV-2 mAbs used here (Brouwer et al., 2020). N.P.K. has a nonprovisional US patent (no. 14/930,792) related to I53-50 (Bale et al., 2016).

Références

Proc Natl Acad Sci U S A. 2017 Aug 29;114(35):E7348-E7357
pubmed: 28807998
Science. 2020 Sep 18;369(6510):1501-1505
pubmed: 32703906
Science. 2019 Feb 8;363(6427):649-654
pubmed: 30573546
Bioinformatics. 2018 Sep 15;34(18):3094-3100
pubmed: 29750242
Retrovirology. 2015 Sep 26;12:82
pubmed: 26410741
Radiology. 2020 Jun;295(3):715-721
pubmed: 32053470
Science. 2020 Mar 13;367(6483):1260-1263
pubmed: 32075877
Nat Nanotechnol. 2020 Aug;15(8):716-723
pubmed: 32601450
N Engl J Med. 2012 Dec 13;367(24):2284-95
pubmed: 23136909
Nat Commun. 2020 Aug 21;11(1):4207
pubmed: 32826924
Nature. 2020 Oct;586(7830):578-582
pubmed: 32731258
N Engl J Med. 2020 Oct 15;383(16):1544-1555
pubmed: 32722908
Cell. 2020 Nov 25;183(5):1367-1382.e17
pubmed: 33160446
Cell. 2020 Jul 9;182(1):73-84.e16
pubmed: 32425270
J Exp Med. 2020 Nov 2;217(11):
pubmed: 32692348
J Struct Biol. 2009 Apr;166(1):95-102
pubmed: 19263523
Euro Surveill. 2020 Jan;25(3):
pubmed: 31992387
Sci Adv. 2021 Mar 19;7(12):
pubmed: 33608249
Vaccine. 2020 Nov 25;38(50):7892-7896
pubmed: 33139139
J Clin Microbiol. 2020 Oct 21;58(11):
pubmed: 32826322
Ultramicroscopy. 1999 Jul;77(3-4):153-61
pubmed: 10406132
Vaccine. 2018 Jan 2;36(1):148-154
pubmed: 29174683
Sci Adv. 2021 Mar 19;7(12):
pubmed: 33741598
ACS Cent Sci. 2021 Jan 27;7(1):183-199
pubmed: 33527087
J Exp Med. 2017 Jul 3;214(7):2139-2152
pubmed: 28637884
J Virol. 1998 Nov;72(11):8463-71
pubmed: 9765382
PLoS Pathog. 2020 Aug 11;16(8):e1008665
pubmed: 32780770
Cell. 2020 Apr 16;181(2):281-292.e6
pubmed: 32155444
Science. 2016 Jul 22;353(6297):389-94
pubmed: 27463675
Science. 2020 Jul 3;369(6499):77-81
pubmed: 32376603
Mol Ther. 2006 Dec;14(6):883-92
pubmed: 16959541
J Virol. 2002 Sep;76(17):8875-89
pubmed: 12163607
Nat Commun. 2021 Jan 11;12(1):244
pubmed: 33431842
Nat Commun. 2019 Oct 11;10(1):4660
pubmed: 31604920
Comput Struct Biotechnol J. 2015 Nov 26;14:58-68
pubmed: 26862374
Nature. 2020 May;581(7809):465-469
pubmed: 32235945
Cell. 2019 Mar 7;176(6):1420-1431.e17
pubmed: 30849373
Lancet Infect Dis. 2020 Apr;20(4):425-434
pubmed: 32105637
Nat Commun. 2021 Mar 1;12(1):1346
pubmed: 33649323
Cell Rep Med. 2021 Oct 19;2(10):100420
pubmed: 34604818
J Clin Invest. 2019 Jul 2;129(8):3185-3200
pubmed: 31264971
Genome Res. 2017 May;27(5):722-736
pubmed: 28298431
Nat Commun. 2019 Sep 19;10(1):4272
pubmed: 31537780
Cell. 2020 Oct 29;183(3):730-738.e13
pubmed: 32979942
Science. 2020 Aug 21;369(6506):956-963
pubmed: 32540903
Expert Rev Vaccines. 2019 Mar;18(3):269-280
pubmed: 30707635
Proc Natl Acad Sci U S A. 2020 May 26;117(21):11727-11734
pubmed: 32376634
Nature. 2021 Mar;591(7851):639-644
pubmed: 33461210
J Clin Invest. 2016 Mar 1;126(3):799-808
pubmed: 26928033
Cell. 2020 Aug 6;182(3):713-721.e9
pubmed: 32778225
Nat Commun. 2020 Mar 13;11(1):1334
pubmed: 32170079
Nature. 2020 Oct;586(7830):583-588
pubmed: 32731257
Immunity. 2020 Dec 15;53(6):1315-1330.e9
pubmed: 33275896
Cell. 2020 Oct 1;183(1):169-184.e13
pubmed: 32931734
Nat Commun. 2015 Sep 03;6:8143
pubmed: 26333350
Nat Commun. 2019 May 29;10(1):2355
pubmed: 31142746
Science. 2014 Dec 12;346(6215):1380-1383
pubmed: 25504724
Nature. 2020 Sep;585(7826):584-587
pubmed: 32698191
Lancet Infect Dis. 2020 Jun;20(6):697-706
pubmed: 32224310
mBio. 2021 Mar 2;12(2):
pubmed: 33653892
Emerg Infect Dis. 2020 Jul;26(7):1478-1488
pubmed: 32267220
Science. 2020 Aug 14;369(6505):806-811
pubmed: 32434945
Science. 2020 Jul 17;369(6501):330-333
pubmed: 32366695
ACS Nano. 2018 Sep 25;12(9):8855-8866
pubmed: 30028591
Genome Res. 2012 Mar;22(3):568-76
pubmed: 22300766
Nature. 2013 Jul 4;499(7456):102-6
pubmed: 23698367
Nat Rev Immunol. 2010 Nov;10(11):787-96
pubmed: 20948547
Cell. 2015 Dec 17;163(7):1702-15
pubmed: 26687358
Science. 2020 Aug 7;369(6504):643-650
pubmed: 32540902
Nat Med. 2020 May;26(5):681-687
pubmed: 32327758
Nat Commun. 2021 Jan 14;12(1):372
pubmed: 33446655
Protein Sci. 2018 Jan;27(1):14-25
pubmed: 28710774

Auteurs

Philip J M Brouwer (PJM)

Department of Medical Microbiology, Amsterdam UMC, University of Amsterdam, Amsterdam Infection & Immunity Institute, 1105 AZ Amsterdam, the Netherlands.

Mitch Brinkkemper (M)

Department of Medical Microbiology, Amsterdam UMC, University of Amsterdam, Amsterdam Infection & Immunity Institute, 1105 AZ Amsterdam, the Netherlands.

Pauline Maisonnasse (P)

Center for Immunology of Viral, Auto-immune, Hematological and Bacterial Diseases (IMVA-HB/IDMIT), Université Paris-Saclay, INSERM, CEA, Fontenay-aux-Roses, France.

Nathalie Dereuddre-Bosquet (N)

Center for Immunology of Viral, Auto-immune, Hematological and Bacterial Diseases (IMVA-HB/IDMIT), Université Paris-Saclay, INSERM, CEA, Fontenay-aux-Roses, France.

Marloes Grobben (M)

Department of Medical Microbiology, Amsterdam UMC, University of Amsterdam, Amsterdam Infection & Immunity Institute, 1105 AZ Amsterdam, the Netherlands.

Mathieu Claireaux (M)

Department of Medical Microbiology, Amsterdam UMC, University of Amsterdam, Amsterdam Infection & Immunity Institute, 1105 AZ Amsterdam, the Netherlands.

Marlon de Gast (M)

Department of Medical Microbiology, Amsterdam UMC, University of Amsterdam, Amsterdam Infection & Immunity Institute, 1105 AZ Amsterdam, the Netherlands.

Romain Marlin (R)

Center for Immunology of Viral, Auto-immune, Hematological and Bacterial Diseases (IMVA-HB/IDMIT), Université Paris-Saclay, INSERM, CEA, Fontenay-aux-Roses, France.

Virginie Chesnais (V)

Life and Soft, 92350 Le Plessis-Robinson, France.

Ségolène Diry (S)

Life and Soft, 92350 Le Plessis-Robinson, France.

Joel D Allen (JD)

School of Biological Sciences, University of Southampton, Southampton SO17 1BJ, UK.

Yasunori Watanabe (Y)

School of Biological Sciences, University of Southampton, Southampton SO17 1BJ, UK; Oxford Glycobiology Institute, Department of Biochemistry, University of Oxford, Oxford OX1 3QU, UK.

Julia M Giezen (JM)

Department of Medical Microbiology, Amsterdam UMC, University of Amsterdam, Amsterdam Infection & Immunity Institute, 1105 AZ Amsterdam, the Netherlands.

Gius Kerster (G)

Department of Medical Microbiology, Amsterdam UMC, University of Amsterdam, Amsterdam Infection & Immunity Institute, 1105 AZ Amsterdam, the Netherlands.

Hannah L Turner (HL)

Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA 92037, USA.

Karlijn van der Straten (K)

Department of Medical Microbiology, Amsterdam UMC, University of Amsterdam, Amsterdam Infection & Immunity Institute, 1105 AZ Amsterdam, the Netherlands.

Cynthia A van der Linden (CA)

Department of Medical Microbiology, Amsterdam UMC, University of Amsterdam, Amsterdam Infection & Immunity Institute, 1105 AZ Amsterdam, the Netherlands.

Yoann Aldon (Y)

Department of Medical Microbiology, Amsterdam UMC, University of Amsterdam, Amsterdam Infection & Immunity Institute, 1105 AZ Amsterdam, the Netherlands.

Thibaut Naninck (T)

Center for Immunology of Viral, Auto-immune, Hematological and Bacterial Diseases (IMVA-HB/IDMIT), Université Paris-Saclay, INSERM, CEA, Fontenay-aux-Roses, France.

Ilja Bontjer (I)

Department of Medical Microbiology, Amsterdam UMC, University of Amsterdam, Amsterdam Infection & Immunity Institute, 1105 AZ Amsterdam, the Netherlands.

Judith A Burger (JA)

Department of Medical Microbiology, Amsterdam UMC, University of Amsterdam, Amsterdam Infection & Immunity Institute, 1105 AZ Amsterdam, the Netherlands.

Meliawati Poniman (M)

Department of Medical Microbiology, Amsterdam UMC, University of Amsterdam, Amsterdam Infection & Immunity Institute, 1105 AZ Amsterdam, the Netherlands.

Anna Z Mykytyn (AZ)

Department of Viroscience, Erasmus Medical Center, 3015 GD Rotterdam, the Netherlands.

Nisreen M A Okba (NMA)

Department of Viroscience, Erasmus Medical Center, 3015 GD Rotterdam, the Netherlands.

Edith E Schermer (EE)

Department of Medical Microbiology, Amsterdam UMC, University of Amsterdam, Amsterdam Infection & Immunity Institute, 1105 AZ Amsterdam, the Netherlands.

Marielle J van Breemen (MJ)

Department of Medical Microbiology, Amsterdam UMC, University of Amsterdam, Amsterdam Infection & Immunity Institute, 1105 AZ Amsterdam, the Netherlands.

Rashmi Ravichandran (R)

Department of Biochemistry, University of Washington, Seattle, WA 98195, USA; Institute for Protein Design, University of Washington, Seattle, WA 98195, USA.

Tom G Caniels (TG)

Department of Medical Microbiology, Amsterdam UMC, University of Amsterdam, Amsterdam Infection & Immunity Institute, 1105 AZ Amsterdam, the Netherlands.

Jelle van Schooten (J)

Department of Medical Microbiology, Amsterdam UMC, University of Amsterdam, Amsterdam Infection & Immunity Institute, 1105 AZ Amsterdam, the Netherlands.

Nidhal Kahlaoui (N)

Center for Immunology of Viral, Auto-immune, Hematological and Bacterial Diseases (IMVA-HB/IDMIT), Université Paris-Saclay, INSERM, CEA, Fontenay-aux-Roses, France.

Vanessa Contreras (V)

Center for Immunology of Viral, Auto-immune, Hematological and Bacterial Diseases (IMVA-HB/IDMIT), Université Paris-Saclay, INSERM, CEA, Fontenay-aux-Roses, France.

Julien Lemaître (J)

Center for Immunology of Viral, Auto-immune, Hematological and Bacterial Diseases (IMVA-HB/IDMIT), Université Paris-Saclay, INSERM, CEA, Fontenay-aux-Roses, France.

Catherine Chapon (C)

Center for Immunology of Viral, Auto-immune, Hematological and Bacterial Diseases (IMVA-HB/IDMIT), Université Paris-Saclay, INSERM, CEA, Fontenay-aux-Roses, France.

Raphaël Ho Tsong Fang (RHT)

Center for Immunology of Viral, Auto-immune, Hematological and Bacterial Diseases (IMVA-HB/IDMIT), Université Paris-Saclay, INSERM, CEA, Fontenay-aux-Roses, France.

Julien Villaudy (J)

AIMM Therapeutics BV, 1105 BA Amsterdam, the Netherlands.

Kwinten Sliepen (K)

Department of Medical Microbiology, Amsterdam UMC, University of Amsterdam, Amsterdam Infection & Immunity Institute, 1105 AZ Amsterdam, the Netherlands.

Yme U van der Velden (YU)

Department of Medical Microbiology, Amsterdam UMC, University of Amsterdam, Amsterdam Infection & Immunity Institute, 1105 AZ Amsterdam, the Netherlands.

Bart L Haagmans (BL)

Department of Viroscience, Erasmus Medical Center, 3015 GD Rotterdam, the Netherlands.

Godelieve J de Bree (GJ)

Department of Internal Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam Institute for Infection and Immunity, 1105 AZ Amsterdam, the Netherlands.

Eric Ginoux (E)

Life and Soft, 92350 Le Plessis-Robinson, France.

Andrew B Ward (AB)

Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA 92037, USA.

Max Crispin (M)

School of Biological Sciences, University of Southampton, Southampton SO17 1BJ, UK.

Neil P King (NP)

Department of Biochemistry, University of Washington, Seattle, WA 98195, USA; Institute for Protein Design, University of Washington, Seattle, WA 98195, USA.

Sylvie van der Werf (S)

Molecular Genetics of RNA Viruses, Department of Virology, Institut Pasteur, CNRS UMR 3569, Université de Paris, Paris, France; National Reference Center for Respiratory Viruses, Institut Pasteur, Paris, France.

Marit J van Gils (MJ)

Department of Medical Microbiology, Amsterdam UMC, University of Amsterdam, Amsterdam Infection & Immunity Institute, 1105 AZ Amsterdam, the Netherlands.

Roger Le Grand (R)

Center for Immunology of Viral, Auto-immune, Hematological and Bacterial Diseases (IMVA-HB/IDMIT), Université Paris-Saclay, INSERM, CEA, Fontenay-aux-Roses, France. Electronic address: roger.le-grand@cea.fr.

Rogier W Sanders (RW)

Department of Medical Microbiology, Amsterdam UMC, University of Amsterdam, Amsterdam Infection & Immunity Institute, 1105 AZ Amsterdam, the Netherlands. Electronic address: r.w.sanders@amsterdamumc.nl.

Articles similaires

Robotic Surgical Procedures Animals Humans Telemedicine Models, Animal

Odour generalisation and detection dog training.

Lyn Caldicott, Thomas W Pike, Helen E Zulch et al.
1.00
Animals Odorants Dogs Generalization, Psychological Smell
Animals TOR Serine-Threonine Kinases Colorectal Neoplasms Colitis Mice
Animals Tail Swine Behavior, Animal Animal Husbandry

Classifications MeSH